NCT05719779View on ClinicalTrials.gov

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 3, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Oral CancerPharynx CancerSleep ApneaSnoringOral Squamous Cell Carcinoma
Interventions
DEVICE

Ronco-Onco and MAD

Comparison of active over a neutral mandibular advacement oral appliance to assess tolerance and efficacy in oropharyngeal cancer individuals in managing snoring and sleep apnea following radiotherapy of oropharynx.

Trial Locations (1)

H3X 3E4

RECRUITING

CHUM, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER